Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12016851 Modified release pharmaceutical formulations comprising deferiprone

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
April 11, 2022
0
Date of Patent
June 25, 2024
0
Patent Application Number
17717922
0
Patent Citations
‌
US Patent 8268352 Modified release composition for highly soluble drugs
0
‌
US Patent 8563035 Oral tablet compositions of dexlansoprazole
0
‌
US Patent 8703156 Liquid formulation for deferiprone with palatable taste
0
‌
US Patent 10940115 Delayed release deferiprone tablets and methods of using the same
0
‌
US Patent 10780055 Delayed release deferiprone tablets and methods of using the same
0
‌
US Patent 10940116 Delayed release deferiprone tablets and methods of using the same
0
‌
US Patent 7049328 Use for deferiprone
0
‌
US Patent 8263125 Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients
0
Patent Inventor Names
Micol Cirilli
0
Marisa Pertile
0
Matteo Cerea
0
Andrea Gazzaniga
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12016851
0
Patent Primary Examiner
‌
Michael B. Pallay
0
CPC Code
‌
A61K 9/2054
0
‌
A61K 31/4412
0

Find more entities like US Patent 12016851 Modified release pharmaceutical formulations comprising deferiprone

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.